A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)

• Status: Completed
• Trial end date: 2010-07-01

Summary

The purpose of this study is to evaluate the long-term safety and efficacy of VI-0521 compared to placebo for the treatment of overweight and obesity in adults who have completed study OB-303 (NCT00553787) at selected study sites. This is an extension study of protocol OB-303 (NCT00553787).

• Phase: Phase 3

Details

• Lead Sponsor: VIVUS, Inc.
• Collaborator: Medpace, Inc.
• Treatments: Phentermine; Topiramate